Orgenesis Announces Collaboration with Digilab to Develop Industrial 3D Printing Capability for Cellular Structures and Tissues for Clinical Use

Orgenesis Inc., a developer, manufacturer and service provider of advanced cell therapies, today announced that it has entered into a collaboration agreement with Digilab Inc. to develop a live cell printing process and systems designed to automate the production of three-dimensional live cellular structures and tissues.  Under the Agreement, Orgenesis will have the exclusive rights

Read More


An unexpected connection between insulin receptor and gene expression opens new doors

The discovery of insulin in the 1920s marked the breakthrough in the almost 3,500-year-long mystery of diabetes, a disease first described in ancient Egyptian papyruses. Until its discovery, physicians struggled to explain how symptoms such as sugary urine, constant thirst and frequent urination could lead to ailments ranging from blindness and nerve damage to coma

Read More


European Innovation Hub to Focus on Developing and Implementing 3D Printed Electronics

More and more, we are using special industrial 3D printers, with inkjet and aerosol jet technology, to embed conductive components within our intelligent products in what we call 3D printed electronics. Items like ECG electrodes and contactless payment cards use these embedded components to perform wireless activities and readings, like measuring the frequency of a person’s heart beats

Read More


Statement on FDA’s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk

Stem cell therapies offer the potential to treat or even cure diseases or conditions for which few effective treatment options exist. Cell based therapies are one of the most promising new fields of science and medicine. These products hold tremendous potential for transformative and potentially curative treatments for some of the most devastating diseases and

Read More


WHO WE ARE

Dr. Pier Maria Fornasari is Scientific Director and CEO of REGENHEALTHSOLUTIONS.Degree in Medicine and Surgery, specialized in Internal Medicine, Clinic and Laboratory Haematology, Anaesthesiology and Health Statistics. Since 1976 researcher at the University of Pavia on extracorporeal blood manipulation in critical patients. Since 1995 to 2015, Director of the Transfusion Medicine/ Musculoskeletal Cell and Tissue

Read More